vs
Side-by-side financial comparison of Idexx Laboratories (IDXX) and RPM INTERNATIONAL INC (RPM). Click either name above to swap in a different company.
RPM INTERNATIONAL INC is the larger business by last-quarter revenue ($1.9B vs $1.1B, roughly 1.8× Idexx Laboratories). Idexx Laboratories runs the higher net margin — 22.8% vs 8.4%, a 14.3% gap on every dollar of revenue. On growth, Idexx Laboratories posted the faster year-over-year revenue change (14.3% vs 3.5%). Idexx Laboratories produced more free cash flow last quarter ($326.3M vs $296.4M). Over the past eight quarters, RPM INTERNATIONAL INC's revenue compounded faster (12.0% CAGR vs 6.4%).
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions.
BVS Entertainment, Inc., formerly known as Saban Productions, Saban International and Saban Entertainment, is a subsidiary of the Walt Disney Company. Founded on April 24, 1980, as a music production company by Haim Saban and Shuki Levy, it slowly transitioned to or gravitated towards television production and distribution, where it is most known for producing and distributing children's programs for Fox Family/ABC Family and defunct channels Fox Kids and Jetix.
IDXX vs RPM — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $1.9B |
| Net Profit | $248.2M | $161.2M |
| Gross Margin | 60.3% | 40.8% |
| Operating Margin | 28.9% | 11.0% |
| Net Margin | 22.8% | 8.4% |
| Revenue YoY | 14.3% | 3.5% |
| Net Profit YoY | 14.8% | -12.0% |
| EPS (diluted) | $3.09 | $1.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | $1.9B | ||
| Q3 25 | $1.1B | $2.1B | ||
| Q2 25 | $1.1B | $2.1B | ||
| Q1 25 | $998.4M | $1.5B | ||
| Q4 24 | $954.3M | $1.8B | ||
| Q3 24 | $975.5M | $2.0B | ||
| Q2 24 | $1.0B | $2.0B | ||
| Q1 24 | $964.1M | $1.5B |
| Q4 25 | $248.2M | $161.2M | ||
| Q3 25 | $274.6M | $227.6M | ||
| Q2 25 | $294.0M | $225.8M | ||
| Q1 25 | $242.7M | $52.0M | ||
| Q4 24 | $216.1M | $183.2M | ||
| Q3 24 | $232.8M | $227.7M | ||
| Q2 24 | $203.3M | $180.6M | ||
| Q1 24 | $235.6M | $61.2M |
| Q4 25 | 60.3% | 40.8% | ||
| Q3 25 | 61.8% | 42.3% | ||
| Q2 25 | 62.6% | 42.4% | ||
| Q1 25 | 62.4% | 38.4% | ||
| Q4 24 | 59.8% | 41.4% | ||
| Q3 24 | 61.1% | 42.5% | ||
| Q2 24 | 61.7% | 41.4% | ||
| Q1 24 | 61.5% | 39.9% |
| Q4 25 | 28.9% | 11.0% | ||
| Q3 25 | 32.1% | 14.1% | ||
| Q2 25 | 33.6% | 11.9% | ||
| Q1 25 | 31.7% | 2.8% | ||
| Q4 24 | 27.4% | 11.5% | ||
| Q3 24 | 31.2% | 14.8% | ||
| Q2 24 | 26.3% | 11.9% | ||
| Q1 24 | 31.0% | 5.5% |
| Q4 25 | 22.8% | 8.4% | ||
| Q3 25 | 24.8% | 10.8% | ||
| Q2 25 | 26.5% | 10.8% | ||
| Q1 25 | 24.3% | 3.5% | ||
| Q4 24 | 22.7% | 9.9% | ||
| Q3 24 | 23.9% | 11.6% | ||
| Q2 24 | 20.3% | 9.0% | ||
| Q1 24 | 24.4% | 4.0% |
| Q4 25 | $3.09 | $1.26 | ||
| Q3 25 | $3.40 | $1.77 | ||
| Q2 25 | $3.63 | $1.76 | ||
| Q1 25 | $2.96 | $0.40 | ||
| Q4 24 | $2.62 | $1.42 | ||
| Q3 24 | $2.80 | $1.77 | ||
| Q2 24 | $2.44 | $1.40 | ||
| Q1 24 | $2.81 | $0.47 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $180.1M | $316.6M |
| Total DebtLower is stronger | $450.0M | $2.5B |
| Stockholders' EquityBook value | $1.6B | $3.1B |
| Total Assets | $3.4B | $7.9B |
| Debt / EquityLower = less leverage | 0.28× | 0.80× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $180.1M | $316.6M | ||
| Q3 25 | $208.2M | $297.1M | ||
| Q2 25 | $164.6M | $302.1M | ||
| Q1 25 | $164.0M | $241.9M | ||
| Q4 24 | $288.3M | $268.7M | ||
| Q3 24 | $308.6M | $231.6M | ||
| Q2 24 | $401.6M | $237.4M | ||
| Q1 24 | $397.4M | $248.9M |
| Q4 25 | $450.0M | $2.5B | ||
| Q3 25 | — | $2.7B | ||
| Q2 25 | — | $2.6B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | $617.8M | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.0B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $1.6B | $3.1B | ||
| Q3 25 | $1.6B | $3.1B | ||
| Q2 25 | $1.5B | $2.9B | ||
| Q1 25 | $1.4B | $2.7B | ||
| Q4 24 | $1.6B | $2.7B | ||
| Q3 24 | $1.6B | $2.6B | ||
| Q2 24 | $1.6B | $2.5B | ||
| Q1 24 | $1.6B | $2.3B |
| Q4 25 | $3.4B | $7.9B | ||
| Q3 25 | $3.4B | $7.9B | ||
| Q2 25 | $3.3B | $7.8B | ||
| Q1 25 | $3.2B | $6.6B | ||
| Q4 24 | $3.3B | $6.7B | ||
| Q3 24 | $3.4B | $6.6B | ||
| Q2 24 | $3.4B | $6.6B | ||
| Q1 24 | $3.4B | $6.4B |
| Q4 25 | 0.28× | 0.80× | ||
| Q3 25 | — | 0.87× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | 0.39× | 0.74× | ||
| Q3 24 | — | 0.77× | ||
| Q2 24 | — | 0.79× | ||
| Q1 24 | — | 0.93× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $355.8M | $345.7M |
| Free Cash FlowOCF − Capex | $326.3M | $296.4M |
| FCF MarginFCF / Revenue | 29.9% | 15.5% |
| Capex IntensityCapex / Revenue | 2.7% | 2.6% |
| Cash ConversionOCF / Net Profit | 1.43× | 2.14× |
| TTM Free Cash FlowTrailing 4 quarters | $1.1B | $582.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $355.8M | $345.7M | ||
| Q3 25 | $402.3M | $237.5M | ||
| Q2 25 | $185.7M | $149.2M | ||
| Q1 25 | $238.0M | $91.5M | ||
| Q4 24 | $262.0M | $279.4M | ||
| Q3 24 | $220.1M | $248.1M | ||
| Q2 24 | $248.3M | $181.2M | ||
| Q1 24 | $198.6M | $173.4M |
| Q4 25 | $326.3M | $296.4M | ||
| Q3 25 | $371.2M | $175.0M | ||
| Q2 25 | $151.6M | $78.2M | ||
| Q1 25 | $207.9M | $33.3M | ||
| Q4 24 | $232.8M | $229.5M | ||
| Q3 24 | $192.0M | $197.3M | ||
| Q2 24 | $215.0M | $105.3M | ||
| Q1 24 | $168.3M | $124.6M |
| Q4 25 | 29.9% | 15.5% | ||
| Q3 25 | 33.6% | 8.3% | ||
| Q2 25 | 13.7% | 3.8% | ||
| Q1 25 | 20.8% | 2.3% | ||
| Q4 24 | 24.4% | 12.4% | ||
| Q3 24 | 19.7% | 10.0% | ||
| Q2 24 | 21.4% | 5.2% | ||
| Q1 24 | 17.5% | 8.2% |
| Q4 25 | 2.7% | 2.6% | ||
| Q3 25 | 2.8% | 3.0% | ||
| Q2 25 | 3.1% | 3.4% | ||
| Q1 25 | 3.0% | 3.9% | ||
| Q4 24 | 3.1% | 2.7% | ||
| Q3 24 | 2.9% | 2.6% | ||
| Q2 24 | 3.3% | 3.8% | ||
| Q1 24 | 3.1% | 3.2% |
| Q4 25 | 1.43× | 2.14× | ||
| Q3 25 | 1.47× | 1.04× | ||
| Q2 25 | 0.63× | 0.66× | ||
| Q1 25 | 0.98× | 1.76× | ||
| Q4 24 | 1.21× | 1.53× | ||
| Q3 24 | 0.95× | 1.09× | ||
| Q2 24 | 1.22× | 1.00× | ||
| Q1 24 | 0.84× | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IDXX
| Vet Lab Consumables | $389.0M | 36% |
| Reference Laboratory Diagnostic And Consulting Services | $349.2M | 32% |
| Rapid Assay Products | $76.0M | 7% |
| Recurring Revenue | $70.6M | 6% |
| CAG Diagnostic Capital Instruments | $58.1M | 5% |
| Water Segment | $50.5M | 5% |
| Livestock And Poultry Diagnostics Segment | $37.5M | 3% |
| CAG Diagnostics Service And Accessories | $35.3M | 3% |
| Systems And Hardware | $20.1M | 2% |
| Rebate And Up Front Considerations Arrangements | $2.4M | 0% |
| Extended Warranties And Post Contract Support Revenue | $1.0M | 0% |
RPM
| Construction Products Group Segment | $737.4M | 39% |
| Consumer Segment | $638.6M | 33% |
| Performance Coatings Group Segment | $533.8M | 28% |
